Staff Data Search - جامعة الزقازيق

/ Staff Data Search - جامعة الزقازيق

Not Found

Personal Website

Lubna Abdul -Aziz Abdul- Aziz Muhamed

Faculty Medicine - Department Radiotherapy and Nuclear Medicine
NULL

Scientific degrees

BSc In , [1997]
MSc In NULL, [2002]
(Preliminary Paljmstubban adjuvant therapy and cisplatin in advanced lung cancer from localized non-small cell type.)
PhD In NULL, [2010]
(Alkamiaúy evaluate hormone therapy and sequential comparison Balmetzamn after surgery in breast cancer cases)

الحالة الوظيفية الحالية :

قائم بالعمل

Academic Jobs

معيد : 2/2/2003
Doctor Assisant : 27/4/2003
Doctor : 29/11/2011
Professor Assisant : 30/10/2017
Professor : 29/11/2022

Publications

1 - The Prognostic Role of NEDD9 and P38 Protein Expression Levels in Urinary Bladder Transitional Cell Carcinoma (2017).

2 - CAN RESECTION OF LIVER METASTASIS IMPROVE SURVIVAL AFTER RESECTABILITY CONVERSION CHEMOTHERAPY IN PATIENTS WITH METASTATIC COLO-RECTAL CANCER? (2016).

3 - ROLE OF REDUCED DOSE CHOP WITH RITUXIMAB PLUS INVOLVED FIELD RADIOTHERAPY IN TREATMENT OF EARLY STAGE DIFFUSE LARGE B –CELL LYMPHOMA IN ELDERLY PATIENTS (2016).

4 - Evaluation of four fractionation schedules of radiation therapy in re-irradiation of painful bone metastases. (2016).

5 - ROLE OF S100P AS A NEW PROGNOSTIC MARKER IN WOMEN WITH METASTATIC BREAST CANCER AND ITS CORRELATION WITH BCL2 AND BAX EXPRESSION (2017).

6 - PROGNOSTIC AND PREDICTIVE SIGNIFICANCE OF PROGRAMMED DEATH LIGAND (PD-L1) AND FOXP3 EXPRESSIONS IN TUMOR CELLS AND TUMOR MICROENVIRONMENT IN OVARIAN CANCER PATIENTS (2017).

7 - Prognostic role of Epithelial-Mesenchymal Transition (EMT) markers SNAIL-1& Eph A2 expression in breast carcinoma (2017).

8 - Stem cell markers epithelial cell adhesion molecule (EpCAM) & cluster of differentiation (CD44) expression in colon cancer patients in relation to prognosis and survival (2017).

9 - Promoter methylation and expression of DNA repair genes MGMT and ERCC1 in tissue and blood of rectal cancer patients (2018).

10 - Prognostic Value of TWIST1 and EZH2 Expression in Colon Cancer (2019).

11 - Tolerability and outcome of sunitinib by giving 4/2 schedule versus 2/1 schedule in metastatic renal cell carcinoma patients: a prospective randomized multi-centric Egyptian study (2020).

12 - Forkhead box M1 over-expression and dachshund homolog 1 downregulation as novel biomarkers for progression of endometrial carcinoma in Egyptian patients (2021).

13 - Clinicopathological and Prognostic Values of Gankyrin, Snail1, and IDH1 Expression in Renal Cell Carcinoma Patients (2022).

14 - Choosing the Appropriate Individualized Adjuvant Chemotherapy in Stage III Colon Cancer Patients Under and Over 70 Years (2021).

15 - Comparison between the risk of ipsilateral breast tumor recurrence after breast-conserving surgery in early breast cancer cases treated by whole breast irradiation with and without boost in patients ≥ 50 years old (2022).

16 - Prognostic significance of lymphocyte-to-monocyte ratio in patients with classical Hodgkin lymphoma before and after receiving first-line chemotherapy (2022).

17 - The validity of giving adjuvant capecitabine after standard anthracycline and/or taxanes based Neo-/Adjuvant Chemotherapy in Early Triple-Negative breast cancer patients: An Egyptian prospective multicentric phase III trial (2022).

Research Area